RAB2A and metabolic dysfunction-associated steatotic liver disease: Through genetic and cellular studies, we demonstrated that nutrition repletion inactivates AMPK-TBC1D1 signaling, augments the level of GTP-bound Rab2A, and then increases the protein stability of PPARγ and the expression of PPARγ target genes, and ultimately contributes to the development of NAFLD.